n i c e o n e. GO BMSN. good timing too. Biotechs are notorious for subpar financials, especially before phase I. You think this is Google? Apples and oranges, my friend.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.